RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Bristol Myers Squibb Company

A collection of news and information related to Bristol Myers Squibb Company published by this site and its partners.

Top Bristol Myers Squibb Company Articles

Displaying items 34-39
  • Old HIV drug found to produce rare liver problem, FDA says

     
    Didanosine, the second drug approved for the treatment of HIV infections and one of the oldest weapons in the AIDS armamentarium, has been found to produce rare cases of potentially fatal liver disease in patients taking it for long periods,......
  • A bitter pill for Big Pharma

    The strategy that has made the pharmaceutical industry one of the wealthiest and most powerful on Earth is finally starting to betray it. Beginning in just a few weeks, and continuing over the next several years, some of the biggest-selling and most...
  • Use of atypical antipsychotics for lesser disorders is gaining ground, despite safety concerns

    Use of atypical antipsychotics for lesser disorders is gaining ground, despite safety concerns
    About a year ago, patients began trooping into the office of UCLA psychiatrist Andrew Leuchter, asking whether an antipsychotic drug called Abilify "might be right for them." Few appeared to be delusional, plagued by hallucinations or suffering fearsome...
  • A Girl Is Given an Adult Medicine and She Pays a Heavy Price

    When a hospital psychiatrist prescribed an antidepressant called Serzone for their 15-year-old daughter, Jimmie and Brenda Robinson assumed it was safe. The episode in February 1997 haunts them--Alissa Robinson nearly died while taking Serzone. After...
  • Cheers are subdued for native son

    Church bells rang in celebration of a native son's rise to power in the Vatican, but many Germans gave the new pontiff less than ringing endorsements. Even in these Bavarian foothills, the heavily Catholic homeland of the former Cardinal Joseph...
  • Many executives delivered 'bang for the buck'

    For 2004, a year that saw the shares of T. Rowe Price Group Inc. surge more than 31 percent, company chief executive George A. Roche received a more modest 21.7 percent bump in his compensation - just about all from performance bonuses. In short, a half-...